RE: News imminent29 Oct 2016 20:02
If you read September's update (only 6 weeks ago) it sounds pretty upbeat to me:
- "Substantive progress in commercialisation discussions..."
- "Significant progress advancing..."
- "improvement of drug release..."
- "scale-up and optimisation..."
- "Well-funded with period-end cash..."
- "Planning to conduct small-scale exploratory pharmacokinetic (PK) trials..."
- "significant progress advancing the OXPzeroTM technology..." "...with details to be announced separately in due course"
- "Ongoing dialogue including the initiation of broader outreach"
- "Proceeding to seek pre-IND meetings"
- "ongoing partnership discussions"
- "significant, disruptive and valuable opportunities"
- "We will update shareholders in due course on our commercial discussions and wider development plans."
etc.
Now how this will affect us in the near/mid term needs to be seen, but it does sound rather positive and ambitious to me. I'll be happily surprised.